CanadaBis Capital Inc. (CANB.V)
CAD 0.09
(0.0%)
CAD 0.09
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 7.1 Million CAD | 56.72% |
| 2022 | 4.53 Million CAD | -5.57% |
| 2021 | 4.8 Million CAD | -18.28% |
| 2020 | 5.87 Million CAD | 27.91% |
| 2019 | 4.59 Million CAD | 3220.83% |
| 2018 | 138.35 Thousand CAD | -7.89% |
| 2017 | 150.2 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 1.82 Million CAD | 4.19% |
| 2024 Q1 | 1.76 Million CAD | -11.97% |
| 2024 Q2 | 1.87 Million CAD | 6.0% |
| 2023 Q1 | 1.56 Million CAD | 18.63% |
| 2023 FY | 7.1 Million CAD | 56.72% |
| 2023 Q2 | 1.83 Million CAD | 17.63% |
| 2023 Q4 | 2 Million CAD | 17.84% |
| 2023 Q3 | 1.7 Million CAD | -7.18% |
| 2022 Q4 | 1.31 Million CAD | 23.12% |
| 2022 Q3 | 1.06 Million CAD | -0.65% |
| 2022 Q2 | 1.07 Million CAD | -0.08% |
| 2022 Q1 | 1.07 Million CAD | -32.48% |
| 2022 FY | 4.53 Million CAD | -5.57% |
| 2021 Q4 | 1.59 Million CAD | 37.05% |
| 2021 Q3 | 1.16 Million CAD | 17.24% |
| 2021 Q2 | 991.9 Thousand CAD | -15.99% |
| 2021 Q1 | 1.18 Million CAD | 36.67% |
| 2021 FY | 4.8 Million CAD | -18.28% |
| 2020 FY | 5.87 Million CAD | 27.91% |
| 2020 Q1 | 2.9 Million CAD | -27.07% |
| 2020 Q3 | 913.28 Thousand CAD | -23.57% |
| 2020 Q2 | 1.19 Million CAD | -58.86% |
| 2020 Q4 | 863.84 Thousand CAD | -5.41% |
| 2019 Q2 | -77.27 Thousand CAD | -622.54% |
| 2019 FY | 4.59 Million CAD | 3220.83% |
| 2019 Q3 | 426.43 Thousand CAD | 651.81% |
| 2019 Q1 | 14.78 Thousand CAD | 42.05% |
| 2019 Q4 | 3.98 Million CAD | 833.97% |
| 2018 FY | 138.35 Thousand CAD | -7.89% |
| 2018 Q3 | 30.72 Thousand CAD | 0.0% |
| 2018 Q4 | 10.41 Thousand CAD | -66.12% |
| 2018 Q1 | 5069.00 CAD | -68.91% |
| 2017 Q4 | 16.3 Thousand CAD | 0.0% |
| 2017 FY | 150.2 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 2.96 Million CAD | -139.775% |
| Decibel Cannabis Company Inc. | 40.44 Million CAD | 82.429% |
| Delivra Health Brands Inc. | 7.1 Million CAD | 0.031% |
| Entourage Health Corp. | 3.7 Million CAD | -91.677% |
| Lifeist Wellness Inc. | 17.59 Million CAD | 59.607% |
| Cannara Biotech Inc. | 15.34 Million CAD | 53.68% |
| Medicure Inc. | 13.98 Million CAD | 49.197% |
| PharmaCielo Ltd. | 8.33 Million CAD | 14.706% |
| Rubicon Organics Inc. | 14.22 Million CAD | 50.037% |
| BioSyent Inc. | 17.6 Million CAD | 59.64% |
| Voyageur Pharmaceuticals Ltd. | 1.22 Million CAD | -482.071% |